Neogen Chemicals Ltd

Neogen Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Neogen Chemicals Ltd

₹ 1,941 0.34%
22 Nov - close price
neogenchem.com BSE: 542665 NSE: NEOGEN
About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Key Points

About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades – Strong Relationship with Global Leading Lithium Miners & Processors. [2]

Website BSE NSE
  • Market Cap ₹ 5,121 Cr.
  • Current Price ₹ 1,941
  • High / Low ₹ 2,390 / 1,149
  • Stock P/E 105
  • Book Value ₹ 298
  • Dividend Yield 0.10 %
  • ROCE 10.4 %
  • ROE 7.06 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's median sales growth is 19.5% of last 10 years

Cons

  • Stock is trading at 6.52 times its book value
  • Promoter holding has decreased over last quarter: -5.66%
  • Company has a low return on equity of 9.94% over last 3 years.
  • Debtor days have increased from 106 to 140 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
113 133 157 148 148 186 204 170 168 167 191 167 174
93 109 130 123 124 156 171 141 142 142 157 138 142
Operating Profit 21 24 27 25 24 30 33 29 26 26 34 28 33
OPM % 18% 18% 17% 17% 16% 16% 16% 17% 16% 15% 18% 17% 19%
0 0 1 1 0 1 2 2 2 1 4 3 2
Interest 4 6 5 6 7 7 9 11 11 10 9 9 12
Depreciation 2 4 4 4 4 4 4 5 5 5 5 6 6
Profit before tax 14 14 19 16 14 21 21 16 12 12 23 17 17
Tax % 22% 24% 17% 29% 29% 29% 31% 28% 26% 53% 24% 25% 25%
11 10 16 11 10 15 14 11 9 6 18 12 13
EPS in Rs 4.80 4.49 6.28 4.46 3.97 5.90 5.75 4.58 3.66 2.20 6.71 4.71 4.94
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
66 74 84 100 110 161 239 306 336 487 686 696 699
57 62 71 86 90 132 196 248 272 401 575 581 578
Operating Profit 9 11 13 14 20 29 43 58 64 87 112 116 121
OPM % 14% 16% 15% 14% 18% 18% 18% 19% 19% 18% 16% 17% 17%
0 0 1 0 0 1 1 0 1 1 5 9 10
Interest 4 5 5 5 8 10 12 12 14 19 29 41 40
Depreciation 1 1 1 1 1 2 3 5 7 12 16 20 22
Profit before tax 5 6 8 8 12 18 29 41 44 57 71 64 70
Tax % 23% 41% 37% 39% 33% 39% 28% 30% 29% 22% 30% 31%
4 4 5 5 8 11 21 29 31 45 50 44 49
EPS in Rs 9.13 8.09 11.31 2.59 3.88 5.34 10.48 12.33 13.47 17.93 20.07 16.70 18.56
Dividend Payout % 22% 25% 18% 77% 26% 19% 14% 16% 17% 15% 15% 18%
Compounded Sales Growth
10 Years: 25%
5 Years: 24%
3 Years: 27%
TTM: -4%
Compounded Profit Growth
10 Years: 28%
5 Years: 16%
3 Years: 12%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: 39%
3 Years: 11%
1 Year: 26%
Return on Equity
10 Years: 13%
5 Years: 12%
3 Years: 10%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 4 4 20 20 20 20 23 23 25 25 26 26
Reserves 12 15 19 8 22 31 50 133 160 414 458 739 759
21 25 24 26 69 82 120 137 222 229 370 389 471
16 18 21 27 41 48 56 61 87 131 202 224 218
Total Liabilities 55 63 69 80 152 181 247 355 492 800 1,054 1,378 1,474
13 14 13 17 56 67 83 111 127 285 347 345 362
CWIP 0 0 0 1 1 1 0 3 115 11 36 56 27
Investments 0 0 0 0 0 0 0 0 0 81 77 25 212
42 49 55 62 94 112 163 242 250 423 594 952 873
Total Assets 55 63 69 80 152 181 247 355 492 800 1,054 1,378 1,474

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 3 9 9 0 12 -4 -34 83 1 -30 -115
0 -1 -2 -4 -33 -13 -20 -29 -134 -146 -94 -122
0 -2 -6 -4 33 -0 24 62 51 188 100 217
Net Cash Flow 0 0 1 0 1 -1 0 -1 -0 44 -25 -20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 67 82 78 58 107 94 93 90 85 82 94 140
Inventory Days 187 173 178 190 228 192 188 257 211 258 275 343
Days Payable 124 117 120 130 177 141 111 71 122 131 147 129
Cash Conversion Cycle 130 138 136 117 158 145 169 276 174 209 223 355
Working Capital Days 132 140 140 126 167 142 163 217 164 190 205 319
ROCE % 26% 26% 27% 26% 23% 23% 26% 22% 17% 14% 13% 10%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
64.33% 60.19% 60.19% 60.19% 60.19% 60.18% 60.18% 60.18% 56.89% 56.89% 56.89% 51.22%
0.00% 4.36% 4.28% 3.74% 3.99% 4.13% 4.30% 4.25% 4.51% 4.56% 4.65% 8.17%
18.82% 18.64% 19.33% 19.12% 18.89% 20.01% 19.87% 20.25% 22.85% 22.14% 22.54% 22.48%
16.85% 16.81% 16.20% 16.96% 16.93% 15.68% 15.63% 15.32% 15.75% 16.42% 15.93% 18.12%
No. of Shareholders 34,23039,62638,64240,92649,48851,68647,58145,30047,01848,35646,69846,470

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls